WASHINGTON, D.C., Dec. 6, 2021 – A new review study looking at the current state of neuromodulation therapies being used to treat depression, including rTMS, ECT and others, is available online today in the December issue of The American Journal of Psychiatry.
For many decades, psychiatric treatment has been primarily focused on the development of medications and the development of psychotherapies. A third type of approach gaining attention in recent years is based in the concept that “that psychiatric dysfunction results from abnormal communication within a network of brain regions that regulate mood, thought, and behavior,” the authors write.
The development of a number of neuromodulation and neurostimulation therapies, the authors note...
Read More